(Total Views: 400)
Posted On: 09/18/2018 10:48:13 AM
Post# of 72444
I am talking about the 2 million they received upon signing as per the PR.
Innovation Pharmaceuticals (otcqb:IPIX) ("the Company"
, a clinical stage biopharmaceutical company, today announced that it has entered into a Securities Purchase Agreement (the "Agreement" with Aspire Capital Fund, LLC ("Aspire". The Company received $2 million on signing the agreement selling 5,263,158 shares at price per share of $0.38 which was the closing price of the Company's common stock on June 26, 2018. Under the Agreement the Company can receive an additional $5 million based on clinical, regulatory and business development milestones to be reached prior to September 30, 2018. The specific milestone payments are.
Innovation Pharmaceuticals (otcqb:IPIX) ("the Company"
, a clinical stage biopharmaceutical company, today announced that it has entered into a Securities Purchase Agreement (the "Agreement" with Aspire Capital Fund, LLC ("Aspire". The Company received $2 million on signing the agreement selling 5,263,158 shares at price per share of $0.38 which was the closing price of the Company's common stock on June 26, 2018. Under the Agreement the Company can receive an additional $5 million based on clinical, regulatory and business development milestones to be reached prior to September 30, 2018. The specific milestone payments are. 
(0)
(0)
